{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T14:15:38Z","timestamp":1794492938365,"version":"4.9.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,12,10]],"date-time":"2020-12-10T00:00:00Z","timestamp":1607558400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,12,10]],"date-time":"2020-12-10T00:00:00Z","timestamp":1607558400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Kobayashi Foundation"},{"name":"Tottori University Faculty of Medicine Alumni Association"},{"name":"President of Tottori University"},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP20dk0307075"],"award-info":[{"award-number":["JP20dk0307075"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP20dk0307075"],"award-info":[{"award-number":["JP20dk0307075"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Accumulating evidence suggests that elevated inflammation contributes to the pathophysiology of post-traumatic stress disorder (PTSD) and that anti-inflammatory drugs might be a new treatment strategy for PTSD. It has been reported that beta-hydroxybutyrate (BHB), one of the main ketone bodies produced, can have an anti-inflammatory and antidepressant effect. Here, we investigated the potential anti-anxiety and anti-inflammatory effects of BHB using a rodent PTSD model, induced by single prolonged stress (SPS). Male, Sprague\u2013Dawley rats were employed in this study. Repeated administration of BHB attenuated SPS-induced anxiety-related behaviors evaluated by the elevated plus maze test. SPS increased the serum levels of TNF-\u03b1 and IL-1\u03b2. In contrast, BHB administration partially attenuated the increase of serum TNF-\u03b1. These findings demonstrate that BHB exerts its anxiolytic effects, possibly by inhibiting systemic TNF-\u03b1. Hence, BHB may be a novel therapeutic candidate for the treatment of PTSD.<\/jats:p>","DOI":"10.1038\/s41598-020-78410-2","type":"journal-article","created":{"date-parts":[[2020,12,10]],"date-time":"2020-12-10T06:09:12Z","timestamp":1607580552000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Beta-hydroxybutyrate, an endogenous NLRP3 inflammasome inhibitor, attenuates anxiety-related behavior in a rodent post-traumatic stress disorder model"],"prefix":"10.1038","volume":"10","author":[{"given":"Takehiko","family":"Yamanashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaaki","family":"Iwata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Midori","family":"Shibushita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyohei","family":"Tsunetomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayu","family":"Nagata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naofumi","family":"Kajitani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiko","family":"Miura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryoichi","family":"Matsuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuyoshi","family":"Nishiguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro A.","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daiki","family":"Setoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukihiko","family":"Shirayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gen","family":"Shinozaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Kaneko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,12,10]]},"reference":[{"key":"78410_CR1","doi-asserted-by":"publisher","first-page":"h6161","DOI":"10.1136\/bmj.h6161","volume":"351","author":"JI Bisson","year":"2015","unstructured":"Bisson, J. I., Cosgrove, S., Lewis, C. & Robert, N. P. Post-traumatic stress disorder. BMJ 351, h6161. https:\/\/doi.org\/10.1136\/bmj.h6161 (2015).","journal-title":"BMJ"},{"key":"78410_CR2","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/nrn3339","volume":"13","author":"RK Pitman","year":"2012","unstructured":"Pitman, R. K. et al. Biological studies of post-traumatic stress disorder. Nat. Rev. Neurosci. 13, 769\u2013787. https:\/\/doi.org\/10.1038\/nrn3339 (2012).","journal-title":"Nat. Rev. Neurosci."},{"key":"78410_CR3","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1097\/nmd.0000000000000478","volume":"204","author":"W Gu","year":"2016","unstructured":"Gu, W., Wang, C., Li, Z., Wang, Z. & Zhang, X. Pharmacotherapies for posttraumatic stress disorder: a meta-analysis. J. Nerv. Ment. Dis. 204, 331\u2013338. https:\/\/doi.org\/10.1097\/nmd.0000000000000478 (2016).","journal-title":"J. Nerv. Ment. Dis."},{"key":"78410_CR4","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jad.2020.02.044","volume":"268","author":"JJ Yang","year":"2020","unstructured":"Yang, J. J. & Jiang, W. Immune biomarkers alterations in post-traumatic stress disorder: a systematic review and meta-analysis. J. Affect. Disord. 268, 39\u201346. https:\/\/doi.org\/10.1016\/j.jad.2020.02.044 (2020).","journal-title":"J. Affect. Disord."},{"key":"78410_CR5","doi-asserted-by":"publisher","first-page":"407","DOI":"10.24869\/psyd.2017.407","volume":"29","author":"S Hussein","year":"2017","unstructured":"Hussein, S., Dalton, B., Willmund, G. D., Ibrahim, M. A. A. & Himmerich, H. A systematic review of tumor necrosis factor-alpha in post-traumatic stress disorder: evidence from human and animal studies. Psychiatr. Danub. 29, 407\u2013420. https:\/\/doi.org\/10.24869\/psyd.2017.407 (2017).","journal-title":"Psychiatr. Danub."},{"key":"78410_CR6","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1111\/pcn.12820","volume":"73","author":"H Hori","year":"2019","unstructured":"Hori, H. & Kim, Y. Inflammation and post-traumatic stress disorder. Psychiatry Clin. Neurosci. 73, 143\u2013153. https:\/\/doi.org\/10.1111\/pcn.12820 (2019).","journal-title":"Psychiatry Clin. Neurosci."},{"key":"78410_CR7","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1007\/s11418-017-1103-8","volume":"72","author":"B Lee","year":"2018","unstructured":"Lee, B., Shim, I., Lee, H. & Hahm, D. H. Effect of oleuropein on cognitive deficits and changes in hippocampal brain-derived neurotrophic factor and cytokine expression in a rat model of post-traumatic stress disorder. J. Nat. Med. 72, 44\u201356. https:\/\/doi.org\/10.1007\/s11418-017-1103-8 (2018).","journal-title":"J. Nat. Med."},{"key":"78410_CR8","doi-asserted-by":"publisher","first-page":"357","DOI":"10.4196\/kjpp.2016.20.4.357","volume":"20","author":"B Lee","year":"2016","unstructured":"Lee, B. et al. Effects of systemic administration of ibuprofen on stress response in a rat model of post-traumatic stress disorder. Korean J. Physiol. Pharmacol. 20, 357\u2013366. https:\/\/doi.org\/10.4196\/kjpp.2016.20.4.357 (2016).","journal-title":"Korean J. Physiol. Pharmacol."},{"key":"78410_CR9","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.tem.2013.09.002","volume":"25","author":"JC Newman","year":"2014","unstructured":"Newman, J. C. & Verdin, E. Ketone bodies as signaling metabolites. Trends Endocrinol. Metab. 25, 42\u201352. https:\/\/doi.org\/10.1016\/j.tem.2013.09.002 (2014).","journal-title":"Trends Endocrinol. Metab."},{"key":"78410_CR10","doi-asserted-by":"publisher","first-page":"H1060","DOI":"10.1152\/ajpheart.00646.2012","volume":"304","author":"DG Cotter","year":"2013","unstructured":"Cotter, D. G., Schugar, R. C. & Crawford, P. A. Ketone body metabolism and cardiovascular disease. Am. J. Physiol. Heart Circ. Physiol. 304, H1060-1076. https:\/\/doi.org\/10.1152\/ajpheart.00646.2012 (2013).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"78410_CR11","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/nm.3804","volume":"21","author":"YH Youm","year":"2015","unstructured":"Youm, Y. H. et al. The ketone metabolite beta-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease. Nat. Med. 21, 263\u2013269. https:\/\/doi.org\/10.1038\/nm.3804 (2015).","journal-title":"Nat. Med."},{"key":"78410_CR12","doi-asserted-by":"publisher","first-page":"7677","DOI":"10.1038\/s41598-017-08055-1","volume":"7","author":"T Yamanashi","year":"2017","unstructured":"Yamanashi, T. et al. Beta-hydroxybutyrate, an endogenic NLRP3 inflammasome inhibitor, attenuates stress-induced behavioral and inflammatory responses. Sci. Rep. 7, 7677. https:\/\/doi.org\/10.1038\/s41598-017-08055-1 (2017).","journal-title":"Sci. Rep."},{"key":"78410_CR13","doi-asserted-by":"publisher","DOI":"10.1002\/npr2.12099","author":"N Kajitani","year":"2020","unstructured":"Kajitani, N. et al. Prefrontal cortex infusion of beta-hydroxybutyrate, an endogenous NLRP3 inflammasome inhibitor, produces antidepressant-like effects in a rodent model of depression. Neuropsychopharmacol. Rep. https:\/\/doi.org\/10.1002\/npr2.12099 (2020).","journal-title":"Neuropsychopharmacol. Rep."},{"key":"78410_CR14","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-020-05467-2","author":"AK Kraeuter","year":"2020","unstructured":"Kraeuter, A. K., Mashavave, T., Suvarna, A., van den Buuse, M. & Sarnyai, Z. Effects of beta-hydroxybutyrate administration on MK-801-induced schizophrenia-like behaviour in mice. Psychopharmacology https:\/\/doi.org\/10.1007\/s00213-020-05467-2 (2020).","journal-title":"Psychopharmacology"},{"key":"78410_CR15","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.bbrc.2017.05.184","volume":"490","author":"L Chen","year":"2017","unstructured":"Chen, L., Miao, Z. & Xu, X. Beta-hydroxybutyrate alleviates depressive behaviors in mice possibly by increasing the histone3-lysine9-beta-hydroxybutyrylation. Biochem. Biophys. Res. Commun. 490, 117\u2013122. https:\/\/doi.org\/10.1016\/j.bbrc.2017.05.184 (2017).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"78410_CR16","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1038\/sj.npp.1301605","volume":"33","author":"S Yamamoto","year":"2008","unstructured":"Yamamoto, S. et al. Effects of single prolonged stress and D-cycloserine on contextual fear extinction and hippocampal NMDA receptor expression in a rat model of PTSD. Neuropsychopharmacology 33, 2108\u20132116. https:\/\/doi.org\/10.1038\/sj.npp.1301605 (2008).","journal-title":"Neuropsychopharmacology"},{"key":"78410_CR17","doi-asserted-by":"publisher","first-page":"615","DOI":"10.3389\/fphar.2017.00615","volume":"8","author":"RR Souza","year":"2017","unstructured":"Souza, R. R., Noble, L. J. & McIntyre, C. K. Using the single prolonged stress model to examine the pathophysiology of PTSD. Front. Pharmacol. 8, 615. https:\/\/doi.org\/10.3389\/fphar.2017.00615 (2017).","journal-title":"Front. Pharmacol."},{"key":"78410_CR18","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1111\/jnc.13347","volume":"135","author":"EL Sabban","year":"2015","unstructured":"Sabban, E. L., Laukova, M., Alaluf, L. G., Olsson, E. & Serova, L. I. Locus coeruleus response to single-prolonged stress and early intervention with intranasal neuropeptide Y. J. Neurochem. 135, 975\u2013986. https:\/\/doi.org\/10.1111\/jnc.13347 (2015).","journal-title":"J. Neurochem."},{"key":"78410_CR19","doi-asserted-by":"publisher","first-page":"e101450","DOI":"10.1371\/journal.pone.0101450","volume":"9","author":"YL Miao","year":"2014","unstructured":"Miao, Y. L. et al. Midazolam ameliorates the behavior deficits of a rat posttraumatic stress disorder model through dual 18 kDa translocator protein and central benzodiazepine receptor and neurosteroidogenesis. PLoS ONE 9, e101450. https:\/\/doi.org\/10.1371\/journal.pone.0101450 (2014).","journal-title":"PLoS ONE"},{"key":"78410_CR20","doi-asserted-by":"publisher","first-page":"213","DOI":"10.4062\/biomolther.2014.032","volume":"22","author":"B Lee","year":"2014","unstructured":"Lee, B. et al. L-tetrahydropalmatine ameliorates development of anxiety and depression-related symptoms induced by single prolonged stress in rats. Biomol. Ther. (Seoul) 22, 213\u2013222. https:\/\/doi.org\/10.4062\/biomolther.2014.032 (2014).","journal-title":"Biomol. Ther. (Seoul)"},{"key":"78410_CR21","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1007\/s11011-018-0216-4","volume":"33","author":"ZK Qiu","year":"2018","unstructured":"Qiu, Z. K. et al. Anxiolytic-like effects of paeoniflorin in an animal model of post traumatic stress disorder. Metab. Brain Dis. 33, 1175\u20131185. https:\/\/doi.org\/10.1007\/s11011-018-0216-4 (2018).","journal-title":"Metab. Brain Dis."},{"key":"78410_CR22","doi-asserted-by":"publisher","first-page":"e24620","DOI":"10.1371\/journal.pone.0024620","volume":"6","author":"S Lim","year":"2011","unstructured":"Lim, S. et al. D-\u03b2-hydroxybutyrate is protective in mouse models of Huntington\u2019s disease. PLoS ONE 6, e24620. https:\/\/doi.org\/10.1371\/journal.pone.0024620 (2011).","journal-title":"PLoS ONE"},{"key":"78410_CR23","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1172\/JCI18797","volume":"112","author":"K Tieu","year":"2003","unstructured":"Tieu, K. et al. D-beta-hydroxybutyrate rescues mitochondrial respiration and mitigates features of Parkinson disease. J. Clin. Investig. 112, 892\u2013901. https:\/\/doi.org\/10.1172\/JCI18797 (2003).","journal-title":"J. Clin. Investig."},{"key":"78410_CR24","doi-asserted-by":"publisher","first-page":"7552","DOI":"10.1016\/j.biomaterials.2013.06.043","volume":"34","author":"J Zhang","year":"2013","unstructured":"Zhang, J. et al. 3-Hydroxybutyrate methyl ester as a potential drug against Alzheimer\u2019s disease via mitochondria protection mechanism. Biomaterials 34, 7552\u20137562. https:\/\/doi.org\/10.1016\/j.biomaterials.2013.06.043 (2013).","journal-title":"Biomaterials"},{"key":"78410_CR25","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1254\/jjp.87.143","volume":"87","author":"M Suzuki","year":"2001","unstructured":"Suzuki, M. et al. Effect of beta-hydroxybutyrate, a cerebral function improving agent, on cerebral hypoxia, anoxia and ischemia in mice and rats. Jpn. J. Pharmacol. 87, 143\u2013150 (2001).","journal-title":"Jpn. J. Pharmacol."},{"key":"78410_CR26","doi-asserted-by":"publisher","first-page":"e0165267","DOI":"10.1371\/journal.pone.0165267","volume":"11","author":"D Setoyama","year":"2016","unstructured":"Setoyama, D. et al. Plasma metabolites predict severity of depression and suicidal ideation in psychiatric patients\u2014a multicenter pilot analysis. PLoS ONE 11, e0165267. https:\/\/doi.org\/10.1371\/journal.pone.0165267 (2016).","journal-title":"PLoS ONE"},{"key":"78410_CR27","doi-asserted-by":"publisher","first-page":"196","DOI":"10.3389\/fpsyt.2018.00196","volume":"9","author":"MJ Lisieski","year":"2018","unstructured":"Lisieski, M. J., Eagle, A. L., Conti, A. C., Liberzon, I. & Perrine, S. A. Single-prolonged stress: a review of two decades of progress in a rodent model of post-traumatic stress disorder. Front. Psychiatry 9, 196. https:\/\/doi.org\/10.3389\/fpsyt.2018.00196 (2018).","journal-title":"Front. Psychiatry"},{"key":"78410_CR28","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1038\/nn.2647","volume":"13","author":"EJ Nestler","year":"2010","unstructured":"Nestler, E. J. & Hyman, S. E. Animal models of neuropsychiatric disorders. Nat. Neurosci. 13, 1161\u20131169. https:\/\/doi.org\/10.1038\/nn.2647 (2010).","journal-title":"Nat. Neurosci."},{"key":"78410_CR29","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.pnpbp.2017.04.008","volume":"77","author":"Q Wang","year":"2017","unstructured":"Wang, Q., Timberlake, M. A. 2nd., Prall, K. & Dwivedi, Y. The recent progress in animal models of depression. Prog. Neuropsychopharmacol. Biol. Psychiatry 77, 99\u2013109. https:\/\/doi.org\/10.1016\/j.pnpbp.2017.04.008 (2017).","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"78410_CR30","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/0165-0270(85)90031-7","volume":"14","author":"S Pellow","year":"1985","unstructured":"Pellow, S., Chopin, P., File, S. E. & Briley, M. Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J. Neurosci. Methods 14, 149\u2013167. https:\/\/doi.org\/10.1016\/0165-0270(85)90031-7 (1985).","journal-title":"J. Neurosci. Methods"},{"key":"78410_CR31","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.comppsych.2017.01.015","volume":"74","author":"D Bruenig","year":"2017","unstructured":"Bruenig, D. et al. Genetic and serum biomarker evidence for a relationship between TNF\u03b1 and PTSD in Vietnam war combat veterans. Compr. Psychiatry 74, 125\u2013133. https:\/\/doi.org\/10.1016\/j.comppsych.2017.01.015 (2017).","journal-title":"Compr. Psychiatry"},{"key":"78410_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/jir.2017.0088","volume":"38","author":"A Waheed","year":"2018","unstructured":"Waheed, A., Dalton, B., Wesemann, U., Ibrahim, M. A. A. & Himmerich, H. A systematic review of interleukin-1\u03b2 in post-traumatic stress disorder: evidence from human and animal studies. J. Interferon Cytokine Res. 38, 1\u201311. https:\/\/doi.org\/10.1089\/jir.2017.0088 (2018).","journal-title":"J. Interferon Cytokine Res."},{"key":"78410_CR33","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/s2215-0366(15)00309-0","volume":"2","author":"IC Passos","year":"2015","unstructured":"Passos, I. C. et al. Inflammatory markers in post-traumatic stress disorder: a systematic review, meta-analysis, and meta-regression. Lancet Psychiatry 2, 1002\u20131012. https:\/\/doi.org\/10.1016\/s2215-0366(15)00309-0 (2015).","journal-title":"Lancet Psychiatry"},{"key":"78410_CR34","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/nm.3804","volume":"21","author":"YH Youm","year":"2015","unstructured":"Youm, Y. H. et al. The ketone metabolite \u03b2-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease. Nat. Med. 21, 263\u2013269. https:\/\/doi.org\/10.1038\/nm.3804 (2015).","journal-title":"Nat. Med."},{"key":"78410_CR35","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1007\/s10571-018-0617-2","volume":"38","author":"S Shang","year":"2018","unstructured":"Shang, S., Wang, L., Zhang, Y., Lu, H. & Lu, X. The beta-hydroxybutyrate suppresses the migration of glioma cells by inhibition of NLRP3 inflammasome. Cell. Mol. Neurobiol. 38, 1479\u20131489. https:\/\/doi.org\/10.1007\/s10571-018-0617-2 (2018).","journal-title":"Cell. Mol. Neurobiol."},{"key":"78410_CR36","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1016\/j.celrep.2017.02.004","volume":"18","author":"EL Goldberg","year":"2017","unstructured":"Goldberg, E. L. et al. \u03b2-hydroxybutyrate deactivates neutrophil NLRP3 inflammasome to relieve gout flares. Cell Rep. 18, 2077\u20132087. https:\/\/doi.org\/10.1016\/j.celrep.2017.02.004 (2017).","journal-title":"Cell Rep."},{"key":"78410_CR37","doi-asserted-by":"publisher","first-page":"e32270","DOI":"10.1371\/journal.pone.0032270","volume":"7","author":"DK Kaushik","year":"2012","unstructured":"Kaushik, D. K., Gupta, M., Kumawat, K. L. & Basu, A. NLRP3 inflammasome: key mediator of neuroinflammation in murine Japanese encephalitis. PLoS ONE 7, e32270. https:\/\/doi.org\/10.1371\/journal.pone.0032270 (2012).","journal-title":"PLoS ONE"},{"key":"78410_CR38","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1007\/s10875-010-9440-3","volume":"30","author":"C Jin","year":"2010","unstructured":"Jin, C. & Flavell, R. A. Molecular mechanism of NLRP3 inflammasome activation. J. Clin. Immunol. 30, 628\u2013631. https:\/\/doi.org\/10.1007\/s10875-010-9440-3 (2010).","journal-title":"J. Clin. Immunol."},{"key":"78410_CR39","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.bbi.2012.12.008","volume":"31","author":"M Iwata","year":"2013","unstructured":"Iwata, M., Ota, K. T. & Duman, R. S. The inflammasome: pathways linking psychological stress, depression, and systemic illnesses. Brain. Behav. Immun. 31, 105\u2013114. https:\/\/doi.org\/10.1016\/j.bbi.2012.12.008 (2013).","journal-title":"Brain. Behav. Immun."},{"key":"78410_CR40","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/nrn.2016.69","volume":"17","author":"ES Wohleb","year":"2016","unstructured":"Wohleb, E. S., Franklin, T., Iwata, M. & Duman, R. S. Integrating neuroimmune systems in the neurobiology of depression. Nat. Rev. Neurosci. 17, 497\u2013511. https:\/\/doi.org\/10.1038\/nrn.2016.69 (2016).","journal-title":"Nat. Rev. Neurosci."},{"key":"78410_CR41","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.biopsych.2015.11.026","volume":"80","author":"M Iwata","year":"2016","unstructured":"Iwata, M. et al. Psychological stress activates the inflammasome via release of adenosine triphosphate and stimulation of the purinergic type 2X7 receptor. Biol. Psychiatry 80, 12\u201322. https:\/\/doi.org\/10.1016\/j.biopsych.2015.11.026 (2016).","journal-title":"Biol. Psychiatry"},{"key":"78410_CR42","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.bbi.2017.03.002","volume":"64","author":"FN Kaufmann","year":"2017","unstructured":"Kaufmann, F. N. et al. NLRP3 inflammasome-driven pathways in depression: clinical and preclinical findings. Brain. Behav. Immun. 64, 367\u2013383. https:\/\/doi.org\/10.1016\/j.bbi.2017.03.002 (2017).","journal-title":"Brain. Behav. Immun."},{"key":"78410_CR43","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.jpsychires.2015.10.015","volume":"72","author":"HK Kim","year":"2016","unstructured":"Kim, H. K., Andreazza, A. C., Elmi, N., Chen, W. & Young, L. T. Nod-like receptor pyrin containing 3 (NLRP3) in the post-mortem frontal cortex from patients with bipolar disorder: a potential mediator between mitochondria and immune-activation. J. Psychiatr. Res. 72, 43\u201350. https:\/\/doi.org\/10.1016\/j.jpsychires.2015.10.015 (2016).","journal-title":"J. Psychiatr. Res."},{"key":"78410_CR44","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/s2215-0366(16)30358-3","volume":"4","author":"SH Li","year":"2017","unstructured":"Li, S. H. & Graham, B. M. Why are women so vulnerable to anxiety, trauma-related and stress-related disorders? The potential role of sex hormones. Lancet Psychiatry 4, 73\u201382. https:\/\/doi.org\/10.1016\/s2215-0366(16)30358-3 (2017).","journal-title":"Lancet Psychiatry"},{"key":"78410_CR45","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/j.cellsig.2016.04.005","volume":"28","author":"P Rojas-Morales","year":"2016","unstructured":"Rojas-Morales, P., Tapia, E. & Pedraza-Chaverri, J. \u03b2-hydroxybutyrate: a signaling metabolite in starvation response?. Cell Signal. 28, 917\u2013923. https:\/\/doi.org\/10.1016\/j.cellsig.2016.04.005 (2016).","journal-title":"Cell Signal."},{"key":"78410_CR46","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1126\/science.1227166","volume":"339","author":"T Shimazu","year":"2013","unstructured":"Shimazu, T. et al. Suppression of oxidative stress by \u03b2-hydroxybutyrate, an endogenous histone deacetylase inhibitor. Science 339, 211\u2013214. https:\/\/doi.org\/10.1126\/science.1227166 (2013).","journal-title":"Science"},{"key":"78410_CR47","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1002\/oby.22051","volume":"26","author":"BJ Stubbs","year":"2018","unstructured":"Stubbs, B. J. et al. A ketone ester drink lowers human ghrelin and appetite. Obesity (Silver Spring) 26, 269\u2013273. https:\/\/doi.org\/10.1002\/oby.22051 (2018).","journal-title":"Obesity (Silver Spring)"},{"key":"78410_CR48","doi-asserted-by":"publisher","first-page":"584130","DOI":"10.3389\/fnins.2020.584130","volume":"14","author":"NG Norwitz","year":"2020","unstructured":"Norwitz, N. G. et al. A ketone ester drink enhances endurance exercise performance in Parkinson\u2019s disease. Front. Neurosci. 14, 584130. https:\/\/doi.org\/10.3389\/fnins.2020.584130 (2020).","journal-title":"Front. Neurosci."},{"key":"78410_CR49","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/s0306-4530(97)00044-9","volume":"22","author":"I Liberzon","year":"1997","unstructured":"Liberzon, I., Krstov, M. & Young, E. A. Stress-restress: effects on ACTH and fast feedback. Psychoneuroendocrinology 22, 443\u2013453. https:\/\/doi.org\/10.1016\/s0306-4530(97)00044-9 (1997).","journal-title":"Psychoneuroendocrinology"},{"key":"78410_CR50","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda, Y. Investigation of the freely available easy-to-use software \u201cEZR\u201d for medical statistics. Bone Marrow Transplant. 48, 452\u2013458. https:\/\/doi.org\/10.1038\/bmt.2012.244 (2013).","journal-title":"Bone Marrow Transplant."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-78410-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-78410-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-78410-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T19:22:22Z","timestamp":1670354542000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-78410-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,10]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["78410"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-78410-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,10]]},"assertion":[{"value":"31 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Takehiko Yamanashi reports receiving grant support from the Kobayashi Foundation. Masaaki Iwata reports receiving grant support from GSK Japan and the SENSHIN Medical Research Foundation. The other authors do not have any conflicts of interest to declare.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21629"}}